Answers are grounded in this paper and cite their sources.
Retrospective analysis reveals improved blood flow after angioplasty in patients receiving axillary brachial plexus block, suggesting enhanced outcomes.
Introduction: Axillary brachial plexus block (ABPB) has been introduced for pain control during percutaneous transluminal angioplasty (PTA) of dysfunctional arteriovenous access (AVA). We investigated its impact on blood flow after PTA. Methods: We retrospectively analyzed PTA procedures for dysfunctional AVA between June 2024 and March 2025. Brachial artery flow volume (BAFV) was measured using ultrasonography. Relative improvement (ΔFV = (post-PTA FV − pre-PTA FV) / pre-PTA FV) was compared between ABPB and local anesthesia groups using a linear mixed-effects model adjusted for patient characteristics. Results: Among 1024 PTA procedures (423 patients), ABPB was used in 365 cases (35.6%). Median ΔFV was higher in ABPB than local anesthesia groups (0.90 vs 0.65; p < 0.001). ABPB was associated with greater BAFV improvement (regression coefficient, 0.46; 95% CI, 0.06–0.86; p = 0.02). Conclusion: ABPB was associated with greater improvement in BAFV after PTA. However, potential anesthesia selection bias remains a limitation.
No takes yet. Share an insight, caveat, or question.
Banshodani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: